Related Experiment Videos

Is a targeted intensive intervention effective for improvements in hypertension control? A randomized controlled

Lene Ørskov Reuther1, Maja Skov Paulsen, Morten Andersen

  • 1Department of Clinical Pharmacology, Bispebjerg Hospital, København NV, Denmark. lreu0001@bbh.regionh.dk

Family Practice
|May 9, 2012
PubMed

Insights

Implementing interventions for general practitioners (GPs) did not significantly improve blood pressure (BP) control in hypertensive patients. Neither moderate nor intensive interventions showed additional benefits in reducing BP or the proportion of patients with high BP.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • General Practice

Background:

  • High blood pressure (BP) is a major stroke risk factor, and antihypertensive therapy is crucial for reducing cardiovascular events.
  • Despite treatment, achieving controlled BP in hypertensive patients remains a significant clinical challenge.

Purpose of the Study:

  • To assess the effectiveness of an intervention aimed at improving general practitioners' (GPs) management of hypertension.
  • To determine if targeted interventions can enhance BP control rates in primary care settings.

Main Methods:

  • A cluster randomized trial involving 124 general practices and 2,646 hypertensive patients across three Danish regions.
  • Practices were randomized into intensive intervention, moderately intensive intervention, or control groups.
  • Key outcomes included changes in the proportion of patients with high BP, systolic BP (SBP), and diastolic BP (DBP) from baseline to follow-up.

Main Results:

  • The proportion of patients with high BP decreased by approximately 9% points between 2007 and 2009.
  • Mean SBP significantly reduced by 3.61 mmHg and DBP by 1.99 mmHg during the study period.
  • No significant additional impact on BP reduction was observed in the intervention groups compared to the control group.

Conclusions:

  • Neither the moderate nor the intensive intervention targeting GPs demonstrated a significant impact on improving blood pressure control.
  • The study suggests that current intervention strategies may not be sufficient to enhance BP management in primary care for hypertensive patients.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...